Safety and Tolerability of GATE-251 in Normal Human Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 9, 2016

Primary Completion Date

December 21, 2017

Study Completion Date

December 21, 2017

Conditions

Major Depressive Disorder

Interventions

DRUG

GATE-251

Single dose of GATE-251

DRUG

Placebo

All Listed Sponsors

lead

Ronald M Burch MD PhD

INDUSTRY

NCT04981561 - Safety and Tolerability of GATE-251 in Normal Human Volunteers | Biotech Hunter | Biotech Hunter